Insider Selling: Oscar Health (NYSE:OSCR) CFO Sells 25,135 Shares of Stock

Oscar Health, Inc. (NYSE:OSCR) CFO Richard Scott Blackley sold 25,135 shares of the business’s stock in a transaction that occurred on Tuesday, December 2nd. The stock was sold at an average price of $16.59, for a total transaction of $416,989.65. Following the completion of the transaction, the chief financial officer owned 1,351,034 shares of the company’s stock, valued at $22,413,654.06. This trade represents a 1.83% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink.

Oscar Health Trading Up 0.4%

Shares of NYSE OSCR traded up $0.07 during midday trading on Thursday, hitting $17.17. The stock had a trading volume of 7,737,399 shares, compared to its average volume of 14,589,062. The company has a debt-to-equity ratio of 0.67, a current ratio of 0.92 and a quick ratio of 0.92. Oscar Health, Inc. has a fifty-two week low of $11.20 and a fifty-two week high of $23.80. The firm has a market cap of $4.55 billion, a P/E ratio of -15.33 and a beta of 1.88. The company’s 50-day simple moving average is $18.08 and its 200 day simple moving average is $16.93.

Oscar Health (NYSE:OSCR) last issued its earnings results on Thursday, November 6th. The company reported ($0.53) earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.55) by $0.02. Oscar Health had a negative net margin of 2.16% and a negative return on equity of 21.50%. The company had revenue of $2.93 billion for the quarter, compared to analyst estimates of $3.09 billion. During the same quarter last year, the firm earned ($0.22) EPS. The company’s revenue for the quarter was up 23.2% on a year-over-year basis. Research analysts anticipate that Oscar Health, Inc. will post 0.69 EPS for the current year.

Analysts Set New Price Targets

Several equities research analysts have commented on OSCR shares. Piper Sandler raised shares of Oscar Health from a “neutral” rating to an “overweight” rating and upped their target price for the company from $13.00 to $25.00 in a research note on Tuesday, November 25th. Weiss Ratings reissued a “sell (d)” rating on shares of Oscar Health in a report on Wednesday, October 8th. Barclays raised their price objective on Oscar Health from $11.00 to $13.00 and gave the stock an “underweight” rating in a research note on Monday, November 10th. Wall Street Zen upgraded Oscar Health from a “sell” rating to a “hold” rating in a report on Saturday, November 22nd. Finally, UBS Group increased their price target on Oscar Health from $11.00 to $12.00 and gave the stock a “sell” rating in a report on Friday, November 7th. One investment analyst has rated the stock with a Buy rating, five have assigned a Hold rating and five have issued a Sell rating to the company’s stock. According to data from MarketBeat.com, Oscar Health currently has an average rating of “Reduce” and an average target price of $14.86.

Institutional Investors Weigh In On Oscar Health

Several institutional investors have recently made changes to their positions in the stock. Farther Finance Advisors LLC lifted its holdings in Oscar Health by 4,420.7% during the 3rd quarter. Farther Finance Advisors LLC now owns 1,311 shares of the company’s stock worth $25,000 after purchasing an additional 1,282 shares in the last quarter. LRI Investments LLC increased its holdings in shares of Oscar Health by 377.9% in the second quarter. LRI Investments LLC now owns 1,233 shares of the company’s stock worth $26,000 after purchasing an additional 975 shares during the period. Jones Financial Companies Lllp raised its position in shares of Oscar Health by 7,473.3% in the first quarter. Jones Financial Companies Lllp now owns 2,272 shares of the company’s stock worth $30,000 after buying an additional 2,242 shares in the last quarter. Strs Ohio bought a new stake in Oscar Health during the first quarter valued at $30,000. Finally, Atlantic Union Bankshares Corp purchased a new position in Oscar Health during the second quarter worth about $33,000. Hedge funds and other institutional investors own 75.70% of the company’s stock.

Oscar Health Company Profile

Oscar Health, Inc operates as a health insurance in the United States. The company offers health plans in individual and small group markets, as well as +Oscar, a technology driven platform that help providers and payors directly enable their shift to value-based care. It also provides reinsurance products.